Translation, cross-cultural adaptation, and measurement properties of the Nepali version of the central sensitization inventory (CSI).
Central nervous system sensitization
Clinimetrics
Cross-cultural comparison
Developing countries
Musculoskeletal pain
Nepal
Pain
Pain measurement
Psychometric properties
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
27 Jul 2020
27 Jul 2020
Historique:
received:
23
01
2020
accepted:
21
07
2020
entrez:
29
7
2020
pubmed:
29
7
2020
medline:
11
11
2020
Statut:
epublish
Résumé
Central sensitization is thought to be an important contributing factor in many chronic pain disorders. The Central Sensitization Inventory (CSI) is a patient-reported measure frequently used to assess symptoms related to central sensitization. The aims of the study were to translate and cross-culturally adapt the CSI into Nepali (CSI-NP) and assess its measurement properties. The CSI was translated into Nepali using recommended guidelines. The CSI-NP was then administered on 100 Nepalese adults with sub-acute and chronic musculoskeletal pain with additional demographic and pain-related questions. The CSI-Nepali was administered again about 2 weeks later. Four measurement properties of the CSI-NP were evaluated: (1) internal consistency using Cronbach's alpha, (2) test-retest reliability using intraclass correlation coefficient (ICC The CSI was successfully translated into Nepali. Internal consistency and test-retest reliability were both excellent (Cronbach's alpha = 0.91, and ICC = 0.98). The standard error of measurement was 0.31 and the smallest detectable change was 0.86. Four out of five (80%) a priori hypotheses were met, confirming the construct validity: the CSI-NP correlated strongly with the Pain Catastrophizing Scale total scores (r = 0.50); moderately with the total number of pain descriptors (r = 0.35); weakly with the Numerical Rating Scale (r = 0.25); and women had significantly higher CSI scores than men. However, the CSI scores did not correlate significantly with the total duration of pain, as hypothesized (r = 0.10). The Nepali translation of the CSI demonstrated excellent reliability and construct validity in adults with musculoskeletal pain. It is now available to Nepali health care providers to help assess central sensitization-related signs and symptoms in individuals with musculoskeletal pain in research or clinical practice to advance the understanding of central sensitization in Nepalese samples.
Sections du résumé
BACKGROUND
BACKGROUND
Central sensitization is thought to be an important contributing factor in many chronic pain disorders. The Central Sensitization Inventory (CSI) is a patient-reported measure frequently used to assess symptoms related to central sensitization. The aims of the study were to translate and cross-culturally adapt the CSI into Nepali (CSI-NP) and assess its measurement properties.
METHODS
METHODS
The CSI was translated into Nepali using recommended guidelines. The CSI-NP was then administered on 100 Nepalese adults with sub-acute and chronic musculoskeletal pain with additional demographic and pain-related questions. The CSI-Nepali was administered again about 2 weeks later. Four measurement properties of the CSI-NP were evaluated: (1) internal consistency using Cronbach's alpha, (2) test-retest reliability using intraclass correlation coefficient (ICC
RESULTS
RESULTS
The CSI was successfully translated into Nepali. Internal consistency and test-retest reliability were both excellent (Cronbach's alpha = 0.91, and ICC = 0.98). The standard error of measurement was 0.31 and the smallest detectable change was 0.86. Four out of five (80%) a priori hypotheses were met, confirming the construct validity: the CSI-NP correlated strongly with the Pain Catastrophizing Scale total scores (r = 0.50); moderately with the total number of pain descriptors (r = 0.35); weakly with the Numerical Rating Scale (r = 0.25); and women had significantly higher CSI scores than men. However, the CSI scores did not correlate significantly with the total duration of pain, as hypothesized (r = 0.10).
CONCLUSIONS
CONCLUSIONS
The Nepali translation of the CSI demonstrated excellent reliability and construct validity in adults with musculoskeletal pain. It is now available to Nepali health care providers to help assess central sensitization-related signs and symptoms in individuals with musculoskeletal pain in research or clinical practice to advance the understanding of central sensitization in Nepalese samples.
Identifiants
pubmed: 32718330
doi: 10.1186/s12883-020-01867-1
pii: 10.1186/s12883-020-01867-1
pmc: PMC7385946
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
286Références
Acta Trop. 2020 Feb;202:105263
pubmed: 31711749
Health Qual Life Outcomes. 2017 Dec 4;15(1):236
pubmed: 29202878
Handb Exp Pharmacol. 2012;(214):473-97
pubmed: 23027463
Man Ther. 2011 Oct;16(5):413-8
pubmed: 21632273
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Gerontologist. 2016 Apr;56 Suppl 2:S243-55
pubmed: 26994264
Pain Pract. 2018 Apr;18(4):544-554
pubmed: 28851012
Braz J Phys Ther. 2018 Sep - Oct;22(5):345-346
pubmed: 30126712
Pain. 2011 Mar;152(3 Suppl):S2-S15
pubmed: 20961685
Pain Med. 2020 Sep 1;21(9):1847-1862
pubmed: 32044980
Headache. 2011 Jun;51(6):880-90
pubmed: 21631474
J Relig Health. 2022 Jun;61(3):2331-2385
pubmed: 31535274
BMJ Open. 2019 Mar 27;9(3):e026874
pubmed: 30918037
Pain Physician. 2015 May-Jun;18(3):E333-46
pubmed: 26000680
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
J Pain Res. 2016 Nov 16;9:1057-1066
pubmed: 27895511
Eval Health Prof. 2005 Jun;28(2):212-32
pubmed: 15851774
Clin J Pain. 2016 Jul;32(7):624-30
pubmed: 26418360
Springerplus. 2016 Oct 21;5(1):1837
pubmed: 27818875
Qual Life Res. 2010 May;19(4):539-49
pubmed: 20169472
Qual Life Res. 2014 May;23(4):1199-210
pubmed: 24264803
Health Qual Life Outcomes. 2019 Mar 21;17(1):51
pubmed: 30898138
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
Pain Pract. 2012 Apr;12(4):276-85
pubmed: 21951710
Bull World Health Organ. 2018 May 1;96(5):366-368
pubmed: 29875522
Pain Rep. 2019 Dec 06;4(6):e788
pubmed: 31984293
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
PLoS One. 2017 Dec 7;12(12):e0188719
pubmed: 29216211
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Pain Pract. 2018 Apr;18(4):463-472
pubmed: 28777895
Pain Pract. 2017 Feb;17(2):166-175
pubmed: 26989894
BMC Med Res Methodol. 2010 Mar 18;10:22
pubmed: 20298572
J Orthop Sports Phys Ther. 2018 Aug;48(8):659-664
pubmed: 29625533
Ann Phys Rehabil Med. 2019 May;62(3):174-177
pubmed: 30753895
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
J Occup Environ Med. 2010 Dec;52(12):1186-91
pubmed: 21124244
Pain Pract. 2020 Feb;20(2):188-196
pubmed: 31605651
Health Qual Life Outcomes. 2018 Apr 3;16(1):56
pubmed: 29615048
Pain. 2009 Jul;144(1-2):35-42
pubmed: 19356853
J Pain Res. 2018 Jan 31;11:265-276
pubmed: 29430196
Qual Life Res. 2018 May;27(5):1159-1170
pubmed: 29550964
Ann Phys Rehabil Med. 2021 Jan;64(1):101325
pubmed: 31689540
J Appl Biobehav Res. 2018 Jun;23(2):
pubmed: 30479469
BMC Musculoskelet Disord. 2015 Feb 12;16:25
pubmed: 25887644
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
J Pain. 2013 May;14(5):438-45
pubmed: 23490634
J Manipulative Physiol Ther. 2018 Feb;41(2):92-101
pubmed: 29329739
J Pain Res. 2017 Sep 01;10:2109-2122
pubmed: 28979158